INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo CHAMBERLAIN'S COUGH REMEDY PEPPERMINT
SCHEDULING STATUS:
S0.

PROPRIETARY NAME
(and dosage form):

CHAMBERLAIN'S COUGH REMEDY PEPPERMINT
(Syrup)

COMPOSITION:
Quantity per 5 mL:
Guaifenesin         50 mg
Alcohol         2,96% v/v
Preservatives: 
Benzoic Acid         0,25% m/v
Sodium Benzoate         0,3% m/v

PHARMACOLOGICAL CLASSIFICATION:
A: 10.1 Antitussives and Expectorants.

INDICATIONS:
Alleviation of cough.

CONTRA-INDICATIONS:
Sensitivity to any of the ingredients.

DOSAGE AND DIRECTIONS FOR USE:
Adults:                         Two 5 mL medicine measures every 4 hours.
Children 6 - 12 years old: One 5 mL medicine measure every 4 hours.
If symptoms persist a doctor should be consulted.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Gastro-intestinal discomfort and drowsiness may occur.
Guaifenesin may interfere with diagnostic measurements of urinary 5-hydroxy-indoleacetic acid or vanillylmandelic acid.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
In extremely large doses, Guaifenesin will cause drowsiness, nausea and vomiting.
Treatment is symptomatic and supportive.

IDENTIFICATION:
A dark, reddish-brown, syrupy liquid with a strong peppermint odour and taste.

PRESENTATION:
Bottles of 50 mL and 100 mL.

STORAGE INSTRUCTIONS:
Store in a cool place (below 25°C). KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
D/10.1/50

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pfizer Consumer Healthcare, division of
Warner-Lambert S.A. (Pty) Ltd.
241 Main Road
RETREAT
7945

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
7 February 1983.

Zimbabwe details:
73/22.2.2/128        HR

Updated on this site: January 2005
Source: Pharmaceutical Industry

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2005